HTG Molecular Diagnostics Inc

NASDAQ:HTGM  
6.11
+0.10 (+1.66%)
Products

Htg Receives First Commercial Orders For Its Planned Htg Transcriptome Panel And Announces The Signing Of Two European Early Adopter Program Agreements

Published: 06/22/2021 12:36 GMT
HTG Molecular Diagnostics Inc (HTGM) - Htg Receives First Commercial Orders for Its Planned Htg Transcriptome Panel and Announces the Signing of Two European Early Adopter Program Agreements.
Htg Molecular Diagnostics - Has Now Signed Eap Agreements With Customers in Both US and Europe.
Htg Molecular Diagnostics - Continues to Progress Toward Its Planned Q3 2021 Commercial Launch of Htg Transcriptome Panel.